Virological breakthrough: A risk factor for loss to followup in a large community-based cohort on antiretroviral therapy

AIDS Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Orrell, Catherine ^a   Kaplan, Richard ^a   Wood, Robin ^a   Bekker, Linda Gail ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873875915     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2011/469127     Document Type: Article

References (16)

1. Arnsten J. H., Demas P. A., Farzadegan H., Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical Infectious Diseases 2001 33 8 1417 1423 10.1086/323201 (Pubitemid 32955198)
2. Bangsberg D. R., db@epi-center.ucsf.edu Hecht F. M., Charlebois E. D., Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000 14 4 357 366 10.1097/00002030-200003100-00008 (Pubitemid 30182431)
3. Paterson D. L., Swindells S., Mohr J., Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 2000 133 1 21 30 (Pubitemid 30432540)
4. Nachega J. B., jnachega@jhsph.edu Hislop M., Dowdy D. W., Chaisson R. E., Regensberg L., Maartens G., Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Annals of Internal Medicine 2007 146 8 564 573 (Pubitemid 351650537)
5. Rosenblum M., Deeks S. G., van der Laan M., Bangsberg D. R., The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy. PLoS ONE 2009 4 9, article e7196 2-s2.0-70349645396 10.1371/journal.pone.0007196
6. Oyugi J. H., Byakika-Tusiime J., Charlebois E. D., Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes 2004 36 5 1100 1102 10.1097/00126334-200408150-00014 (Pubitemid 38989377)
7. Nachega J. B., jnachega@jhsph.edu Hislop M., Dowdy D. W., Lo M., Omer S. B., Regensberg L., Chaisson R. E., Maartens G., Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. Journal of Acquired Immune Deficiency Syndromes 2006 43 1 78 84 10.1097/01.qai.0000225015.43266.46 (Pubitemid 44306492)
8. Orrell C., Bangsberg D. R., Badri M., Wood R., Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 2003 17 9 1369 1375 10.1097/00002030-200306130-00011 (Pubitemid 36819851)
9. Mills E. J., emills@cihhrs.org Nachega J. B., Buchan I., Orbinski J., Attaran A., Singh S., Rachlis B., Wu P., Cooper C., Thabane L., Wilson K., Guyatt G. H., Bangsberg D. R., Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. Journal of the American Medical Association 2006 296 6 679 690 10.1001/jama.296.6.679 (Pubitemid 44200639)
10. Orrell C., catherine.orrell@hiv-research.org.za Harling G., Lawn S. D., Kaplan R., McNally M., Bekker L.-G., Wood R., Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antiviral Therapy 2007 12 1 83 88 (Pubitemid 46340429)
11. Department of Health, 2008 National Antenatal Sentinel HIV and Syphilis Prevalence Survey 2009 Eastern Cape, South Africa Department of Health
12. South African National Antiretroviral Treatment Guidelines 2004 1st Eastern Cape, South Africa National Department of Health. http://www.doh.gov.za/ docs/factsheets/guidelines/artguidelines04/intro.pdf
13. National Department of Health SA, Clinical Guidelines for the Management of HIV & AIDS in Adults and Adolescents 2010 National Department of Health SA
14. Barth R. E., r.e.barth@umcutrecht.nl van der Loeff M. F. S., Schuurman R., Hoepelman A. I., Wensing A. M., Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. The Lancet Infectious Diseases 2010 10 3 155 166 10.1016/S1473-3099(09)70328-7
15. Fox M. P., mfox@bu.edu Rosen S., Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Tropical Medicine and International Health 2010 15 supplement 1 1 15 10.1111/j.1365-3156.2010.02508.x
16. Kaplan R., Richard.Kaplan@hiv-research.org.za Orrell C., Zwane E., Bekker L.-G., Wood R., Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS 2008 22 13 1679 1681 10.1097/QAD.0b013e32830ebcee